Therapeutic options for metastatic breast cancer

Patrick G Morris1, Heather L McArthur, Clifford A Hudis

  • 1Memorial Sloan-Kettering Cancer Center, Breast Cancer Medicine Service, NY 10065, New York, USA.

Insights

Metastatic breast cancer (MBC) treatment advances include new chemotherapy schedules and targeted therapies like trastuzumab. These improve outcomes for MBC patients, with ongoing research promising further breakthroughs.

Area of Science:

  • Oncology
  • Medical Research

Background:

  • Metastatic breast cancer (MBC) is currently incurable.
  • Therapeutic strategies for MBC are evolving.
  • Advances in understanding tumor biology are crucial.

Purpose of the Study:

  • To review recent advances in the treatment of metastatic breast cancer.
  • To highlight the role of chemotherapy and targeted therapies.
  • To discuss the impact of these advances on patient prognosis.

Main Methods:

  • Review of current literature on MBC treatment.
  • Analysis of the efficacy of novel chemotherapeutic agents and targeted therapies.
  • Evaluation of combination treatment strategies.

Main Results:

  • Chemotherapy drug selection and scheduling have improved.
  • Targeted therapies (trastuzumab, lapatinib, bevacizumab) show activity in MBC.
  • Combination therapies with chemotherapy have enhanced patient prognosis.

Conclusions:

  • Ongoing research into MBC pathophysiology and biology is essential.
  • Further therapeutic advances are anticipated.
  • Improved understanding will continue to drive treatment innovation.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...